Trius Therapeutics Liabilities:
17.55M for Dec. 31, 2012Trius Therapeutics Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 17.55M |
| Dec. 31, 2012 | 18.49M |
| Sept. 30, 2012 | 18.91M |
| June 30, 2012 | 16.56M |
| March 31, 2012 | 15.05M |
| Dec. 31, 2011 | 18.23M |
| Sept. 30, 2011 | 15.64M |
| June 30, 2011 | 14.86M |
| March 31, 2011 | 5.135M |
| Dec. 31, 2010 | 4.046M |
| Sept. 30, 2010 | 3.528M |
| June 30, 2010 | 73.32M |
| March 31, 2010 | 2.723M |
| Dec. 31, 2009 | 72.88M |
| Sept. 30, 2009 | 53.68M |
| Dec. 31, 2008 | 53.81M |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
TSRX Liabilities Benchmarks
| Companies | |
|---|---|
| Genomic Health | 26.42M |
| Acorda Therapeutics | 173.78M |
| Exelixis | 424.66M |
TSRX Liabilities Rankings
| Overall |
86th percentile 1011 of 7593 |
| Sector |
62nd percentile 245 of 650 in Healthcare |
| Industry |
65th percentile 21 of 61 in Diagnostics & Research |
TSRX Liabilities Range, Past 5 Years
| Minimum | 2.723M | Mar 2010 |
| Maximum | 73.32M | Jun 2010 |
| Average | 25.27M |
TSRX News
Street Insider May 13
